Showing results (151-160 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|September 3, 2026
Serial Fetal Heart Rate Monitoring During Electroconvulsive Therapy in Late Pregnancy: A Case Report of Transition From Succinylcholine to Rocuronium Reversed With NeostigmineKatsuichiro Shimizu, Hiroyuki Muraoka, Tomoe Fujita, et al.
Neuropsychopharmacology Reports|September 7, 2026
Three Adult Cases of ADHD With Comorbid Tic Symptoms Successfully Treated With Guanfacine MonotherapyKoji Tada, Teruo Tada, Takashi Tsuboi, et al.
Neuropsychopharmacology Reports|September 11, 2026
Alcohol Consumption Index as a Novel Risk Marker for HypertensionIchiro Wakabayashi
Neuropsychopharmacology Reports|September 13, 2026
Prevalence of Treatment-Resistant Schizophrenia: A Nationwide Multicenter StudyYusuke Arai, Toru Horinouchi, Hiroyuki Muraoka, et al.
Neuropsychopharmacology Reports|September 20, 2026
Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional StudyWataru Omori, Naoto Kajitani, Mami Okada-Tsuchioka, et al.
Neuropsychopharmacology Reports|October 27, 2020
Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in JapanTatsushi Nagano, Sohei Kimoto, Katsuro Aso, et al.
Neuropsychopharmacology Reports|July 13, 2021
SSRIs: Applications in inflammatory lung disease and implications for COVID-19Claire Kyung Sun Meikle, Justin Fortune Creeden, Cheryl McCullumsmith, et al.
Neuropsychopharmacology Reports|January 6, 2023
Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary studyYusuke Arai, Daimei Sasayama, Kazuaki Kuraishi, et al.
Neuropsychopharmacology Reports|December 30, 2022
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndromeForouzan Elyasi, Seyedehnasibeh Sadati, Fateme Heydari
Neuropsychopharmacology Reports|December 20, 2022
Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis-related health problems among community cannabis users using social networking servicesYuji Masataka, Takeshi Sugiyama, Yoshiyuki Akahoshi, et al.
Pageof 66